Boniva (Ibandronic Acid)

This is a medicine used to help keep bones strong and prevent fractures. It works by slowing down how quickly your body breaks down bone tissue. Doctors use it for certain types of cancer, bone problems, and to treat osteoporosis in women after menopause.

Brand names:Boniva, Bonviva
Medication

What people taking Boniva (Ibandronic Acid) report

Every report comes from a Lived member, sent anonymously.

Have you tried Boniva (Ibandronic Acid) for Postmenopausal Osteoporosis?

NameHow it went

About Boniva (Ibandronic Acid)

What It's For

Ibandronate (also called ibandronic acid) is a prescription medicine for osteoporosis in women who have gone through menopause. Osteoporosis thins the inside of bones so they break more easily, sometimes from a minor fall or with no injury at all. Ibandronate belongs to a group of bone-strengthening medicines called bisphosphonates. In the United States, the monthly tablet is approved both to treat osteoporosis and to prevent it in postmenopausal women at risk, while the injection given every three months is approved only for treatment. Boniva was the original US brand, but Boniva tablets and injection are no longer sold in the US; the same medicine is available as a generic. Bonviva is the brand name used in Europe. Also in Europe, a product called Bondronat uses ibandronic acid at different doses to protect bones in people whose breast cancer has spread to bone and to treat high blood calcium caused by cancer. Those cancer uses are not approved in the US. In clinical trials, ibandronate increased bone density and roughly halved the chance of a new spine (vertebral) fracture over three years. It did not reduce fractures elsewhere in the body in those trials, and later observational studies have not settled whether it lowers hip fracture risk. That gap is worth weighing when choosing among options such as other bisphosphonates (alendronate, risedronate or the infused zoledronic acid) or denosumab, a different kind of bone medicine.

How It Works

Bone is living tissue that is constantly being renewed. Cells called osteoclasts break down old bone while other cells lay down new bone. After menopause this turnover speeds up, and more bone is removed than replaced, so bones gradually become thinner and weaker. Ibandronate attaches to the mineral surface of bone and slows the osteoclasts. With less bone being broken down, bone building can catch up, which on average produces a modest net gain in bone mass and makes the spine less likely to fracture. Because bisphosphonates stay bound to bone for a long time, a single dose keeps working for weeks to months, which is why ibandronate can be taken once a month or given every three months.

Dosage & Administration

Ibandronate comes as a 150 mg tablet taken once a month on the same date each month, or as a 3 mg injection given into a vein every three months. Food, drinks other than water, and other medicines can keep the tablet from being absorbed. The tablet can also irritate the esophagus (the tube from the throat to the stomach). For both reasons, the routine matters. Take it first thing in the morning, before any food, drink or other medicine, and swallow it whole with a full glass (6 to 8 ounces) of plain water, not mineral water, coffee or juice. Do not chew or suck on it. Then stay sitting or standing upright for at least 60 minutes, and wait those 60 minutes before eating, drinking anything except plain water, or taking other medicines, including calcium, vitamins and antacids. If a monthly tablet is missed and the next scheduled dose is more than seven days away, take it the morning after you remember, then return to your usual date. If the next dose is seven or fewer days away, skip the missed tablet and wait. Never take two tablets within the same week. The injection is given by a health professional over 15 to 30 seconds, after a blood test that checks kidney function. A missed injection is given as soon as it can be rescheduled, with the next one three months later. Whichever form is used, people whose diet is short on calcium and vitamin D are usually advised to take supplements, timed away from the tablet.

Side Effects

The most common side effects are back pain, indigestion, diarrhea, pain in the arms or legs, muscle aches and headache. Some people taking the monthly tablet get a short, flu-like reaction with aches, tiredness or fever within a few days of a dose; in one trial this happened to about 9 percent of people and lasted a week or less. Stop the tablet and call your prescriber promptly, before taking another dose, if you develop trouble or pain when swallowing, pain behind the breastbone, or new or worsening heartburn. These can signal irritation or ulcers in the esophagus, which are more likely if the tablet is taken lying down or without enough water. A few uncommon problems linked to bisphosphonates are worth recognizing early, and each calls for a prompt call to your care team. Painful or swollen gums, loosening teeth, numbness or a heavy feeling in the jaw, or poor healing after dental work can be signs of osteonecrosis of the jaw, a rare condition in which an area of jawbone dies and fails to heal. A new dull, aching pain in the thigh, hip or groin can appear weeks or months before an unusual type of thighbone fracture, sometimes without any fall. Severe bone, joint or muscle pain can occur and usually eases after the medicine is stopped. Eye pain or swelling, sensitivity to light or vision changes can signal inflammation in the eye. The injection has rarely caused severe allergic reactions (anaphylaxis), including deaths, which is why it is given where staff can treat a reaction right away.

Interactions & Warnings

Calcium supplements, antacids, and vitamins or minerals containing iron, magnesium or aluminum bind to ibandronate in the gut and stop it from being absorbed, which is why they must wait at least 60 minutes after the tablet. Aspirin and other anti-inflammatory pain relievers such as ibuprofen and naproxen can also irritate the stomach and esophagus, so combining them with the tablet calls for caution. These absorption issues do not apply to the injection. Ibandronate should not be used by people with low blood calcium until it has been corrected, or by anyone allergic to it. The tablet is also unsuitable for people with esophagus problems that slow the passage of food, such as a narrowing (stricture) or achalasia, and for anyone who cannot sit or stand upright for an hour. People with other active stomach or esophagus problems, such as ulcers, inflammation or trouble swallowing, need careful discussion before using the tablet. Ibandronate is not recommended for people with severe kidney disease, defined as a creatinine clearance below 30 mL/min (an estimate of how well the kidneys filter blood). The injection has been linked to kidney damage, so kidney function is checked before every dose. Tell your dentist that you take a bisphosphonate. A dental check before starting is sensible, particularly for people with gum disease, poorly fitting dentures, cancer, chemotherapy or long-term steroid use, because invasive dental work such as an extraction or implant raises the risk of jaw problems. Ibandronate is not intended for anyone who could become pregnant.

What to Expect

Ibandronate does not change how you feel day to day, so its effect is followed with bone density scans and by whether new fractures occur. In the main trial, spine bone density rose steadily and was measurably better than placebo by six months, while the reduction in spine fractures was shown over three years. Other steps continue to matter alongside the medicine: enough calcium and vitamin D, regular weight-bearing exercise, not smoking and limiting alcohol. The best length of treatment has not been established, and the risk of jaw problems may rise the longer a bisphosphonate is used. For that reason, the need for ongoing treatment should be reviewed periodically. People whose fracture risk is low may be advised to stop after three to five years, with their fracture risk rechecked from time to time afterward. People who find the tablet routine difficult, or cannot stay upright for an hour, may be offered the injection or a different medicine instead.

Questions to Ask Your Doctor

  1. 1.Given my fracture risk, especially at the hip, is ibandronate a good fit for me, or would another osteoporosis medicine protect me better?
  2. 2.Would the monthly tablet or the injection every three months suit me better, given my other medicines and daily routine?
  3. 3.Should I see a dentist before starting, and what should I tell my dentist while I am on it?
  4. 4.Do I need calcium or vitamin D supplements, and how should I time them around my dose?
  5. 5.How will we measure whether it is working, and when should we decide whether to continue or take a break?

Last reviewed • Oct 2026

Educational content, not medical advice.